Recent studies have shown that even in a healthy human body, many cancer cells are born every day. However, the reason cancer does not develop immediately is because the human body has inherent resistance (immunity) to attacking cancer cells. Recently, a new type of treatment called” immune checkpoint inhibitors” has emerged, which harnesses this mechanism. Immune checkpoint inhibitors have shown remarkable efficacy in many types of cancer. Let’s learn about its mechanism.

“Mini-Lecture Program by UTokyo Graduate Students and Faculty Members” is a program in which 10-minute mini-lectures are delivered by graduate students and faculty members who have completed the University of Tokyo Future Faculty Program (UTokyo FFP: a program to learn to teach at universities). Six people who delivered excellent lectures in the UTokyo FFP classes will teach their chosen topic in an easy-to-understand way to those who are unfamiliar with the field by utilizing what they learned in the course.

Seek the video by a keyword